Pages that link to "Q43922213"
Jump to navigation
Jump to search
The following pages link to An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions. (Q43922213):
Displaying 50 items.
- New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemia (Q26749177) (← links)
- Genetic abnormalities associated with acute lymphoblastic leukemia (Q26753823) (← links)
- Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine (Q26864460) (← links)
- Childhood acute lymphoblastic leukemia: Integrating genomics into therapy (Q28080463) (← links)
- Integration of cytogenomic data for furthering the characterization of pediatric B-cell acute lymphoblastic leukemia: a multi-institution, multi-platform microarray study (Q30842603) (← links)
- Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients (Q33573735) (← links)
- Expression of Ik6 and Ik8 Isoforms and Their Association with Relapse and Death in Mexican Children with Acute Lymphoblastic Leukemia (Q35679720) (← links)
- Intragenic ERG Deletions Do Not Explain the Biology of ERG-Related Acute Lymphoblastic Leukemia. (Q36096063) (← links)
- CD200/BTLA deletions in pediatric precursor B-cell acute lymphoblastic leukemia treated according to the EORTC-CLG 58951 protocol (Q36115668) (← links)
- Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options (Q36154689) (← links)
- A novel IGH@ gene rearrangement associated with CDKN2A/B deletion in young adult B-cell acute lymphoblastic leukemia (Q36640716) (← links)
- Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia (Q36980511) (← links)
- The role of the RAS pathway in iAMP21-ALL. (Q37245131) (← links)
- Deregulation of DUX4 and ERG in acute lymphoblastic leukemia (Q37483972) (← links)
- A quantitative proteomics approach identifies ETV6 and IKZF1 as new regulators of an ERG-driven transcriptional network. (Q37507603) (← links)
- Risk factors for relapse in childhood acute lymphoblastic leukemia: prediction and prevention (Q38264774) (← links)
- Ikaros and leukaemia (Q38371003) (← links)
- Genomics in acute lymphoblastic leukaemia: insights and treatment implications (Q38381463) (← links)
- Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics (Q39041475) (← links)
- Genetic Basis of Acute Lymphoblastic Leukemia (Q39180500) (← links)
- Illegitimate RAG-mediated recombination events are involved in IKZF1 Δ3-6 deletion in BCR-ABL1 lymphoblastic leukaemia (Q39751939) (← links)
- The genetic landscape of paediatric de novo acute myeloid leukaemia as defined by single nucleotide polymorphism array and exon sequencing of 100 candidate genes (Q39883150) (← links)
- Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study. (Q41556401) (← links)
- IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951. (Q41688725) (← links)
- High expression of miR-125b-2 and SNORD116 noncoding RNA clusters characterize ERG-related B cell precursor acute lymphoblastic leukemia. (Q41823245) (← links)
- Deciphering "B-others": Novel fusion genes driving B-cell acute lymphoblastic leukemia (Q42068556) (← links)
- B lymphoblastic leukemia/lymphoma: new insights into genetics, molecular aberrations, subclassification and targeted therapy (Q42371687) (← links)
- Philadelphia chromosome-like acute lymphoblastic leukemia (Q43431904) (← links)
- Recent advances in the management of pediatric acute lymphoblastic leukemia (Q45105040) (← links)
- CD2-positive B-cell precursor acute lymphoblastic leukemia with an early switch to the monocytic lineage. (Q45891227) (← links)
- High PDGFRA expression does not serve as an effective therapeutic target in ERG-deleted B-cell precursor acute lymphoblastic leukemia (Q49692632) (← links)
- High STAP1 expression in DUX4-rearranged cases is not suitable as therapeutic target in pediatric B-cell precursor acute lymphoblastic leukemia (Q50043074) (← links)
- Prognostic significance of IKZF1 deletion in adult B cell acute lymphoblastic leukemia: a meta-analysis (Q51343198) (← links)
- ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1 deletion in childhood acute lymphoblastic leukemia. (Q52882383) (← links)
- Efficacy and toxicity of a paediatric protocol in teenagers and young adults with Philadelphia chromosome negative acute lymphoblastic leukaemia: results from UKALL 2003. (Q53239133) (← links)
- The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia. (Q53703572) (← links)
- New biological and genetic classification and therapeutically relevant categories in childhood B-cell precursor acute lymphoblastic leukemia (Q57821013) (← links)
- Acute lymphoblastic leukaemia (Q58481753) (← links)
- Acute lymphoblastic leukemia (Q58481759) (← links)
- Cooperative genetic changes in pediatric B-cell precursor acute lymphoblastic leukemia with deletions or mutations ofIKZF1 (Q59529214) (← links)
- Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALL (Q60907701) (← links)
- Advances in biology of acute lymphoblastic leukemia (ALL) and therapeutic implications (Q61449792) (← links)
- Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia (Q64090852) (← links)
- Outcomes of patients with childhood B-cell precursor acute lymphoblastic leukaemia with late bone marrow relapses: long-term follow-up of the ALLR3 open-label randomised trial (Q64096257) (← links)
- Guidelines for genomic array analysis in acquired haematological neoplastic disorders (Q87092957) (← links)
- Refining risk classification in childhood B acute lymphoblastic leukemia: results of DFCI ALL Consortium Protocol 05-001 (Q89239783) (← links)
- Drug Resistance Biomarkers and Their Clinical Applications in Childhood Acute Lymphoblastic Leukemia (Q89497272) (← links)
- Rapid Identification of Key Copy Number Alterations in B- and T-Cell Acute Lymphoblastic Leukemia by Digital Multiplex Ligation-Dependent Probe Amplification (Q90403224) (← links)
- Characterization of novel, recurrent genomic rearrangements as sensitive MRD targets in childhood B-cell precursor ALL (Q91558232) (← links)
- Acute lymphoblastic leukaemia (Q91565663) (← links)